Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report ; volume:48 ; number:12 ; day:2 ; month:8 ; year:2023 ; pages:1769-1777 ; date:11.2023
Neuropsychopharmacology ; 48, Heft 12 (2.8.2023), 1769-1777, 11.2023
- Creator
-
Garel, Nicolas
Greenway, Kyle T.
Dinh-Williams, Lê-Anh L.
Thibault-Levesque, Julien
Jutras-Aswad, Didier
Turecki, Gustavo
Rej, Soham
Richard-Devantoy, Stephane
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41386-023-01689-y
- URN
-
urn:nbn:de:101:1-2024010508001922919014
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garel, Nicolas
- Greenway, Kyle T.
- Dinh-Williams, Lê-Anh L.
- Thibault-Levesque, Julien
- Jutras-Aswad, Didier
- Turecki, Gustavo
- Rej, Soham
- Richard-Devantoy, Stephane
- SpringerLink (Online service)
Other Objects (12)
Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Personalized use of ketamine and esketamine for treatment-resistant depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Withdrawal-induced delirium associated with a benzodiazepine switch: a case report
Delayed crises following benzodiazepine withdrawal: deficient adaptive mechanisms or simple pharmacokinetics? Detoxification assisted by serum-benzodiazepine elimination tracking
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Personalized use of ketamine and esketamine for treatment-resistant depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Withdrawal-induced delirium associated with a benzodiazepine switch: a case report
Delayed crises following benzodiazepine withdrawal: deficient adaptive mechanisms or simple pharmacokinetics? Detoxification assisted by serum-benzodiazepine elimination tracking
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report
A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatment-Resistant Depression
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Personalized use of ketamine and esketamine for treatment-resistant depression
Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment
Ketamine in multiple treatment-resistant depressed inpatients: a naturalistic cohort study
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
Withdrawal-induced delirium associated with a benzodiazepine switch: a case report
Delayed crises following benzodiazepine withdrawal: deficient adaptive mechanisms or simple pharmacokinetics? Detoxification assisted by serum-benzodiazepine elimination tracking